TrialBMC cancer2021

A randomized phase III study of short-course radiotherapy combined with Temozolomide in elderly patients with newly diagnosed glioblastoma; Japan clinical oncology group study JCOG1910 (AgedGlio-PIII).

Yoshiki Arakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.